These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3462320)

  • 1. Apoprotein B: a discriminator of coronary heart disease.
    Sung ML; Tsai TY; Liang YH; Wang CS; Lin CH; Hsieh CC; Lue SA
    Taiwan Yi Xue Hui Za Zhi; 1986 Apr; 85(4):368-75. PubMed ID: 3462320
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of lipids (cholesterol, triglycerides and phospholipids), plasma lipoproteins (HDL-cholesterol) and apoproteins (apo A and apo B in patients with acute myocardial infarction].
    Paniagua J; Martínez Muñoz A; Tuset N; Gras J
    Med Clin (Barc); 1989 Jun; 93(4):134-8. PubMed ID: 2796436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia.
    Karpe F; Steiner G; Olivecrona T; Carlson LA; Hamsten A
    J Clin Invest; 1993 Mar; 91(3):748-58. PubMed ID: 8450056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Disorders in the quantitative and qualitative composition of the serum lipoproteins in ischemic heart disease patients].
    Orbetsov G; Orbetsova V; Dakovska L
    Vutr Boles; 1984; 23(5):100-6. PubMed ID: 6523839
    [No Abstract]   [Full Text] [Related]  

  • 5. [An immunoenzyme method of determining apoprotein B and its diagnostic value in ischemic heart disease].
    Anisimova OIu; Preobrazhenskiĭ SN; Liakishev AA; Preobrazhenskiĭ DV; Samko AN
    Kardiologiia; 1987 Oct; 27(10):39-43. PubMed ID: 3320453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease.
    Biswas S; Ghoshal PK; Mandal SC; Mandal N
    J Cardiol; 2008 Oct; 52(2):118-26. PubMed ID: 18922385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of apolipoprotein B and AI determinations in coronary heart disease].
    Li JZ; Wang JJ; Niu QT
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):351-5, 381-2. PubMed ID: 2510981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol of alpha and beta lipoproteins in ischemic heart disease.
    Alvarado M; Méndez D; Rivera-Hidalgo PR
    Arch Invest Med (Mex); 1981; 12(4):589-98. PubMed ID: 7332395
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum lipids and lipoproteins in children from families with early coronary heart disease.
    Ozme S; Ege M; Ozalp I; Ciliv G
    Turk J Pediatr; 1977; 19(1-2):67-72. PubMed ID: 618037
    [No Abstract]   [Full Text] [Related]  

  • 10. [Dyslipidemia as a risk factor in atherogenesis].
    Panaitescu G; Fica V; Stănescu L; Serban M; Roşca L; Enache M
    Med Interna (Bucur); 1972 Apr; 24(4):423-40. PubMed ID: 5027788
    [No Abstract]   [Full Text] [Related]  

  • 11. Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.
    Gervaise N; Garrigue MA; Lasfargues G; Lecomte P
    Diabetologia; 2000 Jun; 43(6):703-8. PubMed ID: 10907114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Lipid fractions in low density lipoproteins].
    Ilinov P; Popnikolov S
    Vutr Boles; 1973; 12(6):80-7. PubMed ID: 4783965
    [No Abstract]   [Full Text] [Related]  

  • 13. LDL molecular size as risk factor in coronary artery disease.
    Kozma L; Fodor J; Chockalingam A; Sussex B
    Acta Med Hung; 1992-1993; 49(1-2):65-77. PubMed ID: 1296188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triglyceride-rich lipoproteins and the progression of coronary artery disease.
    Hodis HN; Mack WJ
    Curr Opin Lipidol; 1995 Aug; 6(4):209-14. PubMed ID: 7670749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Platelet activity in acute and chronic ischemic cardiopathy].
    Scrobohaci ML; Stăncioiu N; Zătreanu I
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(3):273-82. PubMed ID: 18783
    [No Abstract]   [Full Text] [Related]  

  • 16. Estradiol, testosterone, apolipoproteins, lipoprotein cholesterol, and lipolytic enzymes in men with premature myocardial infarction and angiographically assessed coronary occlusion.
    Mendoza SG; Zerpa A; Carrasco H; Colmenares O; Rangel A; Gartside PS; Kashyap ML
    Artery; 1983; 12(1):1-23. PubMed ID: 6431945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between bilirubin, apolipoprotein B, and coronary artery disease.
    Levinson SS
    Ann Clin Lab Sci; 1997; 27(3):185-92. PubMed ID: 9142370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. apoB-containing lipoprotein particles as risk factors for coronary artery disease.
    Alaupovic P; Blackenhorn DH; Knight-Gibson C; Tavella M; Bard JM; Shafer D; Lee ET; Brasuell J
    Adv Exp Med Biol; 1991; 285():299-309. PubMed ID: 1858560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Various lipoprotein fractions and their relation to ischemic heart disease].
    Palazzuoli V; Mondillo S; Kristodhullu A; De Stefano R; Amatucci G
    G Ital Cardiol; 1983; 13(2):90-4. PubMed ID: 6884650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum magnesium, serum cholesterol and serum lipoproteins in cases of coronary artery disease.
    Bordia A; Sharma SK; Mathur A; Sanghvi LM
    Indian Heart J; 1972 Jul; 24(3):277-81. PubMed ID: 4348910
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.